tert-Butyl cyclobutyl(5-(3,4-dihydro-2H-pyrrol-5-yl)pyridin-2-yl)carbamate

Catalog No. :
ACJUHC901
CAS No. :
1352511-67-1
Molecular Formula :
C18H25N3O2
Molecular Weight :
315.42

IUPAC Name:tert-butyl cyclobutyl(5-(3,4-dihydro-2H-pyrrol-5-yl)pyridin-2-yl)carbamate

tert-Butyl cyclobutyl(5-(3,4-dihydro-2H-pyrrol-5-yl)pyridin-2-yl)carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$993.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl cyclobutyl(5-(3,4-dihydro-2H-pyrrol-5-yl)pyridin-2-yl)carbamate
IUPAC Nametert-butyl cyclobutyl(5-(3,4-dihydro-2H-pyrrol-5-yl)pyridin-2-yl)carbamate
Molecular FormulaC18H25N3O2
Molecular Weight315.42
SMILESO=C(OC(C)(C)C)N(C1CCC1)C2=NC=C(C3=NCCC3)C=C2
InChI KeyMLYXUDUSMHCLHE-UHFFFAOYSA-N
SynonymCyclobutyl-[5-(4,5-dihydro-3H-pyrrol-2-yl)-pyridin-2-yl]-carbamic acid tert-butyl ester;tert-Butyl cyclobutyl(5-(3,4-dihydro-2H-pyrrol-5-yl)pyridin-2-yl)carbamate;Carbamic acid, N-cyclobutyl-N-[5-(3,4-dihydro-2H-pyrrol-5-yl)-2-pyridinyl]-, 1,1-dimethylethyl ester
CAS No.1352511-67-1

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACJUHC901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACJUHC901 route product structure diagram
    ACJUHC9011352511-67-1
Inquiry

2. ACJUHC901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACJUHC901 route product structure diagram
    ACJUHC9011352511-67-1
Inquiry

Comments (0)